While it would seem the Commercialisation Australia program has disappeared for good, however we understand that is not the case. As part of the Entrepreneurs’ Infrastructure Programme a new component will be released in about November 2014 with a grants of up to $250,000 available for start-up companies with innovative ideas that are commercially driven. The new program will be called Commercialising Ideas and operate similar to the Commercialisation Australia program but exclude funding for Experienced Executives and Early Stage Commercialisation.
Similar Posts
The Global R&D Tax Plateau: Why Australian Innovators Can Not Afford to Wait
What if we learn something that keeps innovation advisors up at night: the world’s most generous R&D tax systems are not getting any more gracious? They have hit a plateau, and they…
The “Grow or Die” Mandate: RDTI Growth-Linked Access rule Punishes Innovation
Once upon a time, Australia made a quiet but consequential promise to its innovators. It said: take a risk, do the hard science, spend years chasing a breakthrough that might not come,…
NSW State Budget 2026-27: New Business Measures and Tax Changes Explained
The new financial strategy for New South Wales is here, and it brings important adjustments for your enterprise. Treasurer Daniel Mookhey has delivered what the government terms a relief and reform package….
Secure High-Impact Funding Now With The Future Made In Australia Innovation Fund
The Australian Government launched a massive investment plan for Australian Businesses to support the transition to a net-zero economy. This initiative is the Future Made in Australia Innovation Fund, which provides 1.5…
Strategic Examination of R&D: 6 Benefits for Businesses
Australia has long been celebrated as a “clever country,” boasting world-class research capabilities with a substantial talent pool. But the Strategic Examination of R&D discussion paper reveals a critical challenge! The Department…
RNA Pipeline Grants: Gateway to RNA Manufacturing
If you are in the biotech business or a biotech entrepreneur with a promising RNA therapeutic? You think you can transform patient outcomes, but you are stuck in the funding valley between…
